Article
Repurposing CRISPR-Cas12b for mammalian genome engineering
14 Nov 2018
Abstract excerpt
Abstract The prokaryotic CRISPR-Cas adaptive immune systems provide valuable resources to develop genome editing tools, such as CRISPR-Cas9 and CRISPR-Cas12a/Cpf1. Recently, CRISPR-Cas12b/C2c1, a distinct type V-B system, has been characterized as a dual-RNA-guided DNA endonuclease system. Though being active in vitro, its cleavage activity at endogenous genome remains to be explored. Furthermore, the optimal...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
